Myeloid and megakaryocytic hypoplasia in related standardbreds.

The research article focuses on the study of myeloid and megakaryocytic bone marrow hypoplasia in eight young Standardbred horses, all sired by the same stallion, which led to neutropenia and thrombocytopenia in most. While the cause is unknown, there’s a suspicion of a familial link to the condition.

Study Summary

• The study centred on eight young Standardbred horses from the same father, which presented with myeloid and megakaryocytic bone marrow hypoplasia and mild to severe neutropenia.
• Seven of these horses also had irregularly intermittent thrombocytopenia.
• Initial bone marrow cultures indicated the presence of myeloid progenitor cells, which could respond to external growth factors via differentiation.
• A defect in the bone marrow microenvironment or growth factor is suspected to be the cause, but this remains unconfirmed.
• Four of the horses were autopsied, but no definitive cause for the myeloid hypoplasia was found.
• Seven out of eight horses ultimately died or were euthanized due to their condition; only one horse, which had moderate neutropenia but usual platelet count, has been racing for three years.
• Given the common paternity among the studied horses, a hereditary basis for the disease is suspected.

Understanding the Terminology

• Myeloid and megakaryocytic bone marrow hypoplasia – this is a condition where the bone marrow does not produce enough blood cells, specifically myeloid and megakaryocytic cells. The former are precursors to various types of blood cells like neutrophils while the latter produce platelets.
• Neutropenia – is an abnormally low concentration of neutrophils, a type of white blood cell. Neutrophils are crucial for fighting off infections, particularly those by bacteria and fungi.
• Thrombocytopenia – is a disorder where the patient has an abnormally low number of platelets in the blood. Platelets play a key role in blood clotting and wound healing.

Study Findings

• An interesting observation from the study was a pattern in the horses’ neutrophil counts – there seemed to be a cyclical variation where lymphocyte counts rose when neutrophil numbers decreased and platelet counts dropped when neutrophil counts reduced.
• The bone marrow in these horses was still capable of producing myeloid progenitor cells, but there seemed to be a hold in the further differentiation and development of these cells, which led to the reduction in neutrophils (and platelets in most cases). This led the researchers to suspect a defect in the bone marrow microenvironment or in growth factors, which wasn’t confirmed.